Abstract
Heart failure (HF) is an emerging epidemic affecting 15 million people in the USA and Europe. HF-related mortality was unchanged between 1995 and 2009, despite a decrease in the incidence of cardiovascular disease. Conventional explanations include an aging population and improved treatment of acute myocardial infarction and HF. An adverse relationship between structure and function is the central theme in patients with systolic dysfunction. The normal elliptical ventricular shape becomes spherical in ischemic, valvular, and nonischemic dilated cardiomyopathy. Therapeutic decisions should be made on the basis of ventricular volume rather than ejection fraction. When left ventricular end-systolic volume index exceeds 60 ml/m2, medical therapy, CABG surgery, and mitral repair have limited benefit. This form–function relationship can be corrected by surgical ventricular restoration (SVR), which returns the ventricle to a normal volume and shape. Consistent early and late benefits in the treatment of ischemic dilated cardiomyopathy with SVR have been reported in >5,000 patients from various international centers. The prospective, randomized STICH trial did not confirm these findings and the reasons for this discrepancy are examined in detail. Future surgical options for SVR in nonischemic and valvular dilated cardiomyopathy, and its integration with left ventricular assist devices and cell therapy, are described.
Key Points
-
Heart failure with systolic dysfunction is caused by ventricular dilatation, in which the natural elliptical shape of the heart becomes spherical
-
Ventricular dilatation alters the relationship between structure and function by compromising helical fiber orientation, whereby the oblique fibers become more-transversely orientated leading to reduced myocyte function
-
Management decisions should be made on the basis of ventricular volume rather than ejection fraction, although the value of volume measurement has not been universally accepted in ischemic cardiomyopathy
-
In ischemic disease, surgical therapy addresses the 'triple V' of vessel, valve, and ventricle in concert, rather than separately
-
Effectiveness of surgical ventricular restoration was demonstrated in >5,000 patients and is recommended in European guidelines, thereby contradicting the STICH trial conclusions; the reasons for this discrepancy are fully discussed
-
Future indications for surgical ventricular restoration might include nonischemic cardiomyopathy, valvular heart disease, and in conjunction with ventricular assist devices or cell therapy
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Braunwald, E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337, 1360–1369 (1997).
Hunt, S. A. et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol. 53, e1–e90 (2009).
Remme, W. J. & Swedberg, K. for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22, 1527–1560 (2001).
Roger, V. L. et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 125, e2–e220 (2012).
Mosterd, A. et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur. Heart J. 20, 447–455 (1999).
Velagaleti, R. S. et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118, 2057–2062 (2008).
Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397–1402 (2002).
Bursi, F. et al. Systolic and diastolic heart failure in the community. JAMA 296, 2209–2216 (2006).
O'Connell, J. B. The economic burden of heart failure. Clin. Cardiol. 23 (3 Suppl.), III6–III10 (2000).
Lehmann, C. A. Economic Benefits of e-Technology in Managing Congestive Heart Failure. American Association of Homes and Services for the Aging. LeadingAge [online], (2005).
MacIntyre, K. et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66,547 patients hospitalized between 1986 and 1995. Circulation 102, 1126–1131 (2000).
Gheorghiade, M. & Bonow, R. O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97, 282–289 (1998).
Mehta, P. A. & Cowie, M. R. Gender and heart failure: a population perspective. Heart 92 (Suppl. 3), iii14–iii18 (2006).
Dor, V., Sabatier, M., Montiglio, F., Civaia, F. & DiDonato, M. Endoventricular patch reconstruction of ischemic failing ventricle. A single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail. Rev. 9, 269–286 (2004).
Suma, H., Tanabe, H., Uejima, T., Isomura, T. & Horii, T. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy. Eur. J. Cardiothorac. Surg. 36, 280–284 (2009).
Dor, V., Civaia, F., Alexandrescu, C. & Montiglio, F. The post-myocardial infarction scarred ventricle and congestive heart failure: the pre-eminence of magnetic resonance imaging for preoperative, intraoperative, and postoperative assessment. J. Thorac. Cardiovasc. Surg. 136, 1405–1412 (2008).
Menicanti, L. et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J. Thorac. Cardiovasc. Surg. 134, 433–441 (2007).
O'Neill, J. O. et al. The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. Eur. J. Cardiothorac. Surg. 30, 753–759 (2006).
Adams, J. D. et al. Does preoperative ejection fraction predict operative mortality with left ventricular restoration? Ann. Thorac. Surg. 82, 1715–1719 (2006).
Schreuder, J. J. et al. Acute decrease of left ventricular mechanical dyssynchrony and improvement of contractile state and energy efficiency after left ventricular restoration. J. Thorac. Cardiovasc. Surg. 129, 138–145 (2005).
ten Brinke, E. A. et al. Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: six-month follow-up by pressure-volume loops. J. Thorac. Cardiovasc. Surg. 140, 1338–1344 (2010).
Yamaguchi, A., Adachi, H., Kawahito, K., Murata, S. & Ino, T. Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy. Ann. Thorac. Surg. 79, 456–461 (2005).
Mickleborough, L. L., Merchant, N., Ivanov, J., Rao, V. & Carson, S. Left ventricular reconstruction: early and late results. J. Thorac. Cardiovasc. Surg. 128, 27–37 (2004).
Athanasuleas, C. L. et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J. Am. Coll. Cardiol. 44, 1439–1445 (2004).
Jones, R. H. et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N. Engl. J. Med. 360, 1705–1717 (2009).
Bolognese, L. et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106, 2351–2357 (2002).
Gaudron, P., Eilles, C., Kugler, I. & Ertl, G. Progressive left ventricular dysfunction and remodelling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87, 755–763 (1993).
Klein, M. D., Herman, M. V. & Gorlin, R. A hemodynamic study of left ventricular aneurysm. Circulation 35, 614–630 (1967).
Mann, D. L., Bogaev, R. & Buckberg, G. D. Cardiac remodelling and myocardial recovery: lost in translation? Eur. J. Heart Fail. 12, 789–796 (2010).
Vasan, R. S., Larson, M. G., Benjamin, E. J., Evans, J. C. & Levy, D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N. Engl. J. Med. 336, 1350–1355 (1997).
White, H. D. et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76, 44–51 (1987).
Bockeria, L., Gorodkov, A., Dorofeev, A. & Alshibaya, M. for the RESTORE Group. Left ventricular geometry reconstruction in ischemic cardiomyopathy patients with predominantly hypokinetic left ventricle. Eur. J. Cardiothorac. Surg. 29 (Suppl. 1), S251–S258 (2006).
McManus, D. D. et al. Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study. J. Am. Soc. Echocardiogr. 22, 190–197 (2009).
Migrino, R. Q. et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. Circulation 96, 116–121 (1997).
Carabello, B. A. The changing unnatural history of valvular regurgitation. Ann. Thorac. Surg. 53, 191–199 (1992).
Detaint, D. et al. Congestive heart failure complicating aortic regurgitation with medical and surgical management: a prospective study of traditional and quantitative echocardiographic markers. J. Thorac. Cardiovasc. Surg. 136, 1549–1557 (2008).
Bonow, R. O., Rosing, D. R., Kent, K. M. & Epstein, S. E. Timing of operation for chronic aortic regurgitation. Am. J. Cardiol. 50, 325–336 (1982).
Suri, R. M. et al. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J. Thorac. Cardiovasc. Surg. 137, 1071–1076 (2009).
Clemente, C. D. Anatomy: A Regional Atlas of the Human Body, 5th edn (Lippincott Williams & Wilkins, Philadelphia, 2007).
Moore, K. L. & Dalley, A. F. Clinically Oriented Anatomy, 5th edn (Lippincott Williams & Wilkins, Philadelphia, 2005).
Torrent-Guasp, F. et al. Spatial orientation of the ventricular muscle band: physiologic contribution and surgical implications. J. Thorac. Cardiovasc. Surg. 122, 389–392 (2001).
Bogaert, J. & Rademakers, F. E. Regional nonuniformity of normal adult human left ventricle. Am. J. Physiol. Heart Circ. Physiol. 280, H610–H620 (2001).
Buckberg, G., Hoffman, J. I., Mahajan, A., Saleh, S. & Coghlan, C. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation 118, 2571–2587 (2008).
Sallin, E. A. Fiber orientation and ejection fraction in the human ventricle. Biophys. J. 9, 954–964 (1969).
Mann, D. L. & Bristow, M. R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111, 2837–2849 (2005).
Mann, D. L. Mechanisms and models in heart failure: a combinatorial approach. Circulation 100, 999–1008 (1999).
De Luca, G., Suryapranata, H., Ottervanger, J. P. & Antman, E. M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109, 1223–1225 (2004).
Centurión, O. A. The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the infarct-related coronary artery. Angiology 58, 34–44 (2007).
Babuty, D. & Lab, M. J. Mechanoelectric contributions to sudden cardiac death. Cardiovasc. Res. 50, 270–279 (2001).
Mahrholdt, H. et al. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J. Am. Coll. Cardiol. 42, 505–512 (2003).
Dor, V. et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J. Thorac. Cardiovasc. Surg. 116, 50–59 (1998).
St John Sutton, M. et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 107, 2577–2582 (2003).
Di Donato, M., Sabatier, M., Dor, V. & Buckberg, G. D. for the RESTORE Group. Ventricular arrhythmias after LV remodelling: surgical ventricular restoration or ICD? Heart Fail. Rev. 9, 299–306 (2004).
Braun, J. et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann. Thorac. Surg. 85, 430–436 (2008).
De Bonis, M. et al. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann. Thorac. Surg. 85, 932–939 (2008).
Packer, M. et al. Effect of carvedilol on survival in severe chronic heart failure. N. Engl. J. Med. 344, 1651–1658 (2001).
Elefteriades, J. & Edwards, R. Coronary bypass in left heart failure. Semin. Thorac. Cardiovasc. Surg. 14, 125–132 (2002).
Vanoverschelde, J. L. et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am. J. Cardiol. 85, 1432–1439 (2000).
Louie, H. W. et al. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 84, III290–III295 (1991).
Yamaguchi, A. et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann. Thorac. Surg. 65, 434–438 (1998).
Bax, J. J. et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 110 (Suppl. 1), II18–II22 (2004).
Bolling, S. F. Mitral reconstruction in cardiomyopathy. J. Heart Valve Dis. 11 (Suppl. 1), S26–S31 (2002).
Ciarka, A. et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am. J. Cardiol. 106, 395–401 (2010).
Crabtree, T. D. et al. Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann. Thorac. Surg. 85, 1537–1542 (2008).
Benedetto, U. et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. J. Cardiovasc. Med. (Hagerstown) 10, 109–114 (2009).
Mihaljevic, T. et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J. Am. Coll. Cardiol. 49, 2191–2201 (2007).
Wu, A. H. et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 45, 381–387 (2005).
Calafiore, A. M. et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann. Thorac. Surg. 77, 1989–1997 (2004).
Akar, A. R. et al. Mitral valve relpair and revascularization for ischemic mitral regurgitation: predictors of operative mortality and survival. J. Heart Valve Dis. 11, 793–800 (2002).
Spoor, M. T., Geltz, A. & Bolling, S. F. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 114 (1 Suppl.), I67–I71 (2006).
Hvass, U. & Joudinaud, T. The papillary muscle sling for ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 139, 418–423 (2010).
Buffolo, E., Branco, J. N. & Catani, R. for the RESTORE Group. End-stage cardiomyopathy and secondary mitral insufficiency surgical alternative with prosthesis implant and left ventricular restoration. Eur. J. Cardiothorac. Surg. 29 (Suppl. 1), S266–S271 (2006).
Di Donato, M. et al. Regional myocardial performance of non-ischaemic zones remote from anterior wall left ventricular aneurysm. Effects of aneurysmectomy. Eur. Heart J. 16, 1285–1292 (1995).
Cooley, D. A., Frazier, O. H., Duncan, J. M., Reul, G. J. & Krajcer, Z. Intracavitary repair of ventricular aneurysm and regional dyskinesia. Ann. Surg. 215, 417–423 (1992).
Suma, H. for the RESTORE Group. Left ventriculoplasty for nonischemic dilated cardiomyopathy. Semin. Thorac. Cardiovasc. Surg. 13, 514–521 (2001).
Isomura, T., Horii, T., Suma, H. & Buckberg, G. D. for the RESTORE Group. Septal anterior ventricular exclusion operation (Pacopexy) for ischemic dilated cardiomyopathy: treat form not disease. Eur. J. Cardiothorac. Surg. 29, S245–S250 (2006).
Isomura, T. et al. Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy. Eur. J. Heart Fail. 13, 423–431 (2011).
Walker, W. E. et al. Techniques and results of ventricular aneurysmectomy with emphasis on anteroseptal repair. J. Thorac. Cardiovasc. Surg. 76, 824–831 (1978).
Jatene, A. D. Left ventricular aneurysmectomy. Resection or reconstruction. J. Thorac. Cardiovasc. Surg. 89, 321–331 (1985).
Menicanti, L., Dor, V., Buckberg, G. D., Athanasuleas, C. L. & Di Donato, M. Inferior wall restoration: anatomic and surgical considerations. Semin. Thorac. Cardiovasc. Surg. 13, 504–513 (2001).
Dor, V., Civaia, F., Alexandrescu, C., Sabatier, M. & Montiglio, F. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial. J. Thorac. Cardiovasc. Surg. 141, 905–916 (2011).
Buckberg, G. D. Basic science review: the helix and the heart. J. Thorac. Cardiovasc. Surg. 124, 863–883 (2002).
Cirillo, M. & Arpesella, G. Rewind the heart: a novel technique to reset heart fibers' orientation in surgery for ischemic cardiomyopathy. Med. Hypotheses 70, 848–854 (2008).
Matsui, Y., Fukada, Y., Naito, Y. & Sasaki, S. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure. J. Thorac. Cardiovasc. Surg. 127, 1221–1223 (2004).
Bellenger, N. G. et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur. Heart J. 21, 1387–1396 (2000).
Sun, X. G., Hansen, J. E. & Stringer, W. W. Oxygen uptake efficiency plateau best predicts early death in heart failure. Chest 141, 1284–1294 (2012).
Parrino, P. E. & Kron, I. L. for the RESTORE Group. The role of left ventricular reconstruction for cardiogenic shock. Semin. Thorac. Cardiovasc. Surg. 13, 476–479 (2001).
Hernandez, A. F. et al. Contemporary performance of surgical ventricular restoration procedures: data from the Society of Thoracic Surgeons' National Cardiac Database. Am. Heart J. 152, 494–499 (2006).
Dunlay, S. M. et al. Hospitalizations after heart failure diagnosis a community perspective. J. Am. Coll. Cardiol. 54, 1695–1702 (2009).
Wijns, W. et al. Guidelines on myocardial revascularization. Eur. Heart J. 31, 2501–2555 (2010).
Di Donato, M., Castelvecchio, S. & Menicanti, L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy. Eur. J. Heart Fail. 12, 375–381 (2010).
Carmichael, B. B. et al. Effects of surgical ventricular restoration on left ventricular function: dynamic MR imaging. Radiology 241, 710–717 (2006).
Schenk, S. et al. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 128, 38–43 (2004).
Di Donato, M. et al. Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation 109, 2536–2543 (2004).
Westermann, D. et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 117, 2051–2060 (2008).
Moss, A. J. et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110, 3760–3765 (2004).
Pocar, M. et al. Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy. Eur. J. Cardiothorac. Surg. 37, 1093–1100 (2010).
Ferrazzi, P. et al. Surgical ventricular reverse remodeling in severe ischemic dilated cardiomyopathy: the relevance of the left ventricular equator as a prognostic factor. J. Thorac. Cardiovasc. Surg. 131, 357–363 (2006).
Turakhia, M. & Tseng, Z. H. Sudden cardiac death: epidemiology, mechanisms, and therapy. Curr. Probl. Cardiol. 32, 501–546 (2007).
Hohnloser, S. H. et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N. Engl. J. Med. 351, 2481–2488 (2004).
Bonow, R. O. et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N. Engl. J. Med. 364, 1617–1625 (2011).
Buckberg, G. D. & Athanasuleas, C. L. The STICH trial: misguided conclusions. J. Thorac. Cardiovasc. Surg. 138, 1060–1064 (2009).
Zembala, M. et al. Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. J. Am. Coll. Cardiol. 56, 499–507 (2010).
Oh, J. K. et al. Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. J. Am. Soc. Echocardiogr. 25, 327–336 (2012).
Michler, R. E. et al. Influence of left ventricular volume reduction on outcome after coronary artery bypass grafting with or without surgical ventricular reconstruction. Presented at the 59th ACC Scientific Sessions (2010).
Batista, R. J. et al. Partial left ventriculectomy to treat end-stage heart disease. Ann. Thorac. Surg. 64, 634–638 (1997).
Ascione, R., Lim, K. H., Chamberlain, M., Al Ruzzeh, S. & Angelini, G. D. Early and late results of partial left ventriculectomy: single center experience and review of the literature. J. Card. Surg. 18, 190–196 (2003).
Franco-Cereceda, A. et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation. J. Thorac. Cardiovasc. Surg. 121, 879–893 (2001).
Suma, H., Isomura, T., Horii, T. & Buckberg, G. for the RESTORE Group. Role of site selection for left ventriculoplasty to treat idiopathic dilated cardiomyopathy. Heart Fail. Rev. 9, 329–336 (2004).
Setser, R. M. et al. Noninvasive assessment of cardiac mechanics and clinical outcome after partial left ventriculectomy. Ann. Thorac. Surg. 76, 1576–1585 (2003).
Mann, D. L. et al. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann. Thorac. Surg. 84, 1226–1235 (2007).
Acker, M. A. et al. Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. J. Thorac. Cardiovasc. Surg. 142, 569–574 (2011).
Kawaguchi, A. T., Ujiie, T., Koide, S. & Batista, R. J. in Partial Left Ventriculectomy: Its Theories, Results, and Perspectives (eds Akira, T. & Kawaguchi, A. T.) 59–75 (Elsevier, Tokyo, 1998).
Maybaum, S. et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115, 2497–2505 (2007).
Margulies, K. B. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J. Card. Fail. 8 (6 Suppl.), S500–S505 (2002).
Yacoub, M. H. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur. Heart J. 22, 534–540 (2001).
Caulfield, J. B. & Janicki, J. S. Structure and function of myocardial fibrillar collagen. Technol. Health Care 5, 95–113 (1997).
Malliaras, K. & Marbán, E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br. Med. Bull. 98, 161–185 (2011).
Ott, H. C. et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213–221 (2008).
Levin, H. R. et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91, 2717–2720 (1995).
Trainini, J. C. et al. La bomba de succión cardÃaca. Aplicación de la banda miocárdica de Torrent Guasp al tratamiento quirúrgico de la insuficiencia cardÃaca. Cir. Cardiov. 18, 103–112 (2011).
Williams, J. A. et al. Surgical ventricular restoration versus cardiac transplantation: a comparison of cost, outcomes, and survival. J. Card. Fail. 14, 547–554 (2008).
Trehan, N. et al. Surgical treatment of post infarction left ventricular aneurysms: our experience with double breasting and Dor's repair. J. Card. Surg. 18, 114–120 (2003).
Author information
Authors and Affiliations
Contributions
All the authors contributed substantially to researching data for the article, discussion of content, writing the article, and review/editing before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Buckberg, G., Athanasuleas, C. & Conte, J. Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol 9, 703–716 (2012). https://doi.org/10.1038/nrcardio.2012.143
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2012.143
This article is cited by
-
Outcomes of continuous flow left ventricular assist device after surgical left ventricular restoration
General Thoracic and Cardiovascular Surgery (2023)
-
Non-heart transplant surgical approaches with mitral valve operation and surgical ventricular reconstruction for non-ischaemic dilated cardiomyopathy: a Japanese multicenter study
General Thoracic and Cardiovascular Surgery (2021)
-
Cardiac death in patients with left ventricular aneurysm, remodeling and myocardial viability by gated 99mTc-MIBI SPECT and gated 18F-FDG PET
The International Journal of Cardiovascular Imaging (2018)
-
Posterior ventricular restoration treatment for heart failure: a review, past, present and future aspects
General Thoracic and Cardiovascular Surgery (2017)
-
Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction
Current Treatment Options in Cardiovascular Medicine (2016)